Variation in pneumococcal invasiveness metrics is driven by serotype carriage duration and initial risk of disease
- PMID: 38039595
- PMCID: PMC10786323
- DOI: 10.1016/j.epidem.2023.100731
Variation in pneumococcal invasiveness metrics is driven by serotype carriage duration and initial risk of disease
Abstract
Streptococcus pneumoniae is an opportunistic pathogen that, while usually carried asymptomatically, can cause severe invasive diseases like meningitis and bacteremic pneumonia. A central goal in S. pneumoniae public health management is to identify which serotypes (immunologically distinct strains) pose the most risk of invasive disease. The most common invasiveness metrics use cross-sectional data (i.e., invasive odds ratios (IOR)), or longitudinal data (i.e., attack rates (AR)). To assess the reliability of these metrics we developed an epidemiological model of carriage and invasive disease. Our mathematical analyses illustrate qualitative failures with the IOR metric (e.g., IOR can decline with increasing invasiveness parameters). Fitting the model to both longitudinal and cross-sectional data, our analysis supports previous work indicating that invasion risk is maximal at or near time of colonization. This pattern of early invasive disease risk leads to substantial (up to 5-fold) biases when estimating underlying differences in invasiveness from IOR metrics, due to the impact of carriage duration on IOR. Together, these results raise serious concerns with the IOR metric as a basis for public health decision-making and lend support for multiple alternate metrics including AR.
Keywords: Carriage duration; Compartmental model; Invasive disease; Streptococcus pneumoniae; Virulence.
Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest None.
Figures
References
-
- Alanee SR, McGee L, Jackson D, Chiou CC, Feldman C, Morris AJ, Ortqvist A, Rello J, Luna CM, Baddour LM, Ip M, Yu VL, Klugman KP, International Pneumococcal Study G, 2007. Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin. Infect. Dis. 45, 46–51. - PubMed
-
- Allen RC, Popat R, Diggle SP, Brown SP, 2014. Targeting virulence: can we make evolution-proof drugs? Nat. Rev. Microbiol 12, 300–308. - PubMed
-
- Althouse BM, Hammitt LL, Grant L, Wagner BG, Reid R, Larzelere-Hinton F, Weatherholtz R, Klugman KP, Rodgers GL, O’Brien KL, Hu H, 2017. Identifying transmission routes of Streptococcus pneumoniae and sources of acquisitions in high transmission communities. Epidemiol. Infect. 145, 2750–2758. - PMC - PubMed
-
- Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG, 2003. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J. Infect. Dis. 187, 1424–1432. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
